Nifedipine-loaded polymeric nanoparticles: Preparation and in vitro characterization

Özakar E., Çetin M., Ateş O., Hacımüftüoğlu A.

PAKISTAN JOURNAL OF PHARMACEUTICAL SCIENCES, cilt.32, sa.2, ss.547-554, 2019 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 32 Sayı: 2
  • Basım Tarihi: 2019
  • Dergi Adı: PAKISTAN JOURNAL OF PHARMACEUTICAL SCIENCES
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.547-554
  • Anahtar Kelimeler: FT-IR, in vitro release, nanoparticle, nifedipine, PLGA, DRUG-DELIVERY-SYSTEMS, PLGA NANOPARTICLES, RELEASE
  • Atatürk Üniversitesi Adresli: Evet

Özet

The purpose of the current study was to prepare nifedipine (NF) loaded-PLGA nanoparticles (NPs) using two different methods (nanoprecipitation method (N-2) and emulsion-solvent evaporation method (N-4)) to achieve the sustained release of NF and to reduce its side effects and also to investigate the in vitro characteristics of NPs (surface morphology, particle size and size distribution, encapsulation efficiency and in vitro release characteristics). SEM images of nanoparticles revealed their approximate spherical shape. The mean particle sizes of the prepared nanoparticles ranged from 294.27 +/- 7.93 to 424.92 +/- 4.96 nm with almost neutral zeta potential values (close to 0 mV). The percent encapsulation efficiency values of N-2 and N-4 formulations 13.03 +/- 1.82% and 18.96 +/- 1.95% (p=0.05), respectively. The extents of cumulative drug release from N-2 and N-4 in PB pH 7.4 medium were up to about 100 % in 38 days and 22 days, respectively (when comparing two formulations, p<0.05). PLGA nanoparticles are useful systems for the sustained release of NF, and hence for reducing its side-effects and increasing patient compliance.